{"entity":{"type":"insider","cik":"0001744687","url":"/insider/0001744687","json_url":"/insider/0001744687.json","name":"Alfieri Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2018-09-14","last":"2026-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Alfieri Michael","source":"filing","n_filings":3,"first_seen":"2018-09-14","last_seen":"2026-03-19"}],"transactions":[{"id":6058926,"accession":"0001193125-26-116247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-116247","line_url":"/filing/0001193125-26-116247#line-1","is_derivative":false,"issuer_cik":"0001341235","issuer_name":"Aldeyra Therapeutics, Inc.","issuer_ticker":"ALDX","issuer_name_source":null,"issuer_url":"/issuer/0001341235","owner_cik":"0001744687","owner_name":"Alfieri Michael","owner_display_name":"Alfieri Michael","owner_url":"/insider/0001744687","role":"Officer (Principal Financial Officer)","role_mark":"O","role_mark_label":"Officer (Principal Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.42,"price_display":"1.42","price_state":"stated","total_value":7100.0,"total_display":"7,100.00","total_whole":"7,100","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-19","scope":"insider"},{"id":4419257,"accession":"0000950170-25-109391","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-109391","line_url":"/filing/0000950170-25-109391#line-1","is_derivative":false,"issuer_cik":"0001341235","issuer_name":"Aldeyra Therapeutics, Inc.","issuer_ticker":"ALDX","issuer_name_source":null,"issuer_url":"/issuer/0001341235","owner_cik":"0001744687","owner_name":"Alfieri Michael","owner_display_name":"Alfieri Michael","owner_url":"/insider/0001744687","role":"Officer (Principal Financial Officer)","role_mark":"O","role_mark_label":"Officer (Principal Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":13250.0,"total_display":"13,250.00","total_whole":"13,250","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-15","scope":"insider"},{"id":6110040,"accession":"0001457612-18-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-18-000082","line_url":"/filing/0001457612-18-000082#line-1","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001744687","owner_name":"Alfieri Michael","owner_display_name":"Alfieri Michael","owner_url":"/insider/0001744687","role":"Officer (Principle Financial Officer)","role_mark":"O","role_mark_label":"Officer (Principle Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principle Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.54,"price_display":"0.54","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-13","filed_date":"2018-09-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001341235","name":"Aldeyra Therapeutics, Inc.","url":"/issuer/0001341235","role":"Officer (Principal Financial Officer)","n_filings":2,"first_seen":"2025-08-15","last_seen":"2026-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001457612","name":"GENOCEA BIOSCIENCES, INC.","url":"/issuer/0001457612","role":"Officer (Principle Financial Officer)","n_filings":1,"first_seen":"2018-09-14","last_seen":"2018-09-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001744687","retrieved_at":"2026-08-26T10:22:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}